Endocrinology Fellowship Research

Good mentorship is critical to developing successful academic career. We have the most robust faculty members to mentor research years including the Former Chief – National Institute of Diabetes Digestive & Kidney Diseases, NIH, Former Chief of the Division of Endocrinology and Metabolism at the University of Pittsburgh School of Medicine, recipients of prestigious Aurbach Award of The Endocrine Society, and also those who served as Program Chairs for Annual Scientific Sessions for the American Diabetes Association as well as the Endocrine Society.

The second and optional third years of the fellowship are devoted primarily to research and scholarly activity while further enhancing clinical skills in Endocrinology through continuity clinics and elective rotations. Each fellow, under the guidance of a mentor, defines an area of research, and then designs and conducts a research project. The goal of these second and optional third years is to develop an understanding of the intricacies of clinical or basic scientific research, to enable the fellow to gain expertise in a selected area, and to develop an appreciation of the strengths and pitfalls of laboratory or clinical research. Research projects are formally presented at our semi-annual fellow research conferences. All of the aforementioned are essential steps toward developing a successful academic career.

Learn more about ongoing basic science and clinical research in the Division of Endocrinology, Diabetes and Bone Disease.

Many of our teaching faculty are involved in funded basic/translational and clinical research projects and have experience and expertise in mentoring Fellows.  Below are the areas of active research in our department.


  • Genetics of polycystic ovary syndrome with Dr. Andrea Dunaif
  • Thyroid autoimmunity research with Dr. Terry Davies
  • Metabolism and cancer in a mouse model with Drs. Derek Leroith & Emily Gallagher
  • New treatments for castration-resistant prostate cancer Dr. Alice C. Levine
  • Regeneration of rodent and human pancreatic beta cells for the treatment of both Types 1 and 2 diabetes with Dr. Andrew Stewart
  • Effect of phosphodiesterase 5 inhibition on osteoclast and osteoblast function with Dr. Se-min Kim
  • Characterizing regulatory T cells in patients with autoimmune thyroid disease with Dr. Stephanie Behringer-Massera

  • The relationship of the metabolic syndrome/prediabetes and breast cancer in women with different racial backgrounds with Drs. Derek Leroith & Emily Gallagher
  • Type 1 diabetes and pregnancy; artificial pancreas technologies with Dr. Carol Levy
  • Impact of Vitamin D therapy on bone with Dr. Maria Skamagas
  • Effect of online training on inpatient glycemia with Dr. Ronald Tamler
  • New therapies for mild adrenal cortisol excess (MACE) due to adrenal adenomas in postmenopausal women with Dr. Alice C. Levine
  • Expression of dopamine receptors in resistant prolactinomas with Dr. Alice C. Levine
  • Improving inpatient diabetes management: A Fellow-driven educational initiative with Dr. David Lam

Ilana Ramer Bass: Racial disparities in systemic hyperinsulinemia and breast cancer insulin receptor signaling

Danielle Brooks: Artificial pancreas systems in type 1 diabetes mellitus; diabetes technology use in older adults living with type 1 diabetes mellitus

Emily Anne Japp: Mild autonomous cortisol excess, ectopic ACTH, pheochromocytoma

Samantha Kass Newman: Atypical antibodies to the TSH receptor and Graves’ disease

Amanda Leiter: Impact of metabolic disease on cancer outcomes

Dr. Kaveeta Marwaha: Role of regulatory T cells in thyroid autoimmunity

Dr. Yasmine Elamir: Calcitriol therapy in patients hospitalized with SARS-CoV-2 

Dr. Tania Al Shamy: Impact of obesity and insulin resistance on patients with COVID-19

Dr. Kruti Patel: Phosphodiesterase-5 inhibitor therapy and osteoporosis risk